Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Giant Cell Tumor of Bone 1Depression 1Colonic Polyps 1Carcinoma, Transitional Cell 1Body Weight Changes 1Arthralgia 1Adenomatous Polyps 1

Interventions

Denosumab 3gentamicin-polymethylmethacrylate bead 1fludarabine 1aldesleukin 1Zoledronic Acid 1Vitamin D 1Nivolumab 1Ipilimumab 1Dasatinib 1Cyclophosphamide 1Calcium 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Giant Cell Tumor of Bone × Calcium × Clear all
NCT00396279 2022-11-08

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Amgen

Phase 2 Completed
37 enrolled 13 charts

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡